Stay updated on Immunotherapy Combinations in Solid Cancers Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy Combinations in Solid Cancers Clinical Trial page.

Latest updates to the Immunotherapy Combinations in Solid Cancers Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe record describes a completed Phase 1/2 study of immunotherapy combinations for advanced cancers, with participant eligibility, study locations, treatment arms, and safety and efficacy outcome measures. It also includes study dates, record history, and links to the protocol and sponsor information.SummaryDifference61%

- Check16 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0, while the study page continues to show a 403 error.SummaryDifference0.2%

- Check22 days agoChange DetectedA site-wide NIH banner announces updates to NIH websites and says that “Super Intelligence” is replacing “Artificial Intelligence” in some federal agency content.SummaryDifference1%

- Check29 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check36 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check57 days agoChange DetectedThe page now displays a 403 Forbidden error with the standard header, replacing the usual study record content. The normal study details (locations, conditions, and other metadata) are no longer visible, indicating access is blocked.SummaryDifference18%

Stay in the know with updates to Immunotherapy Combinations in Solid Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy Combinations in Solid Cancers Clinical Trial page.